Abstract
To investigate the effect of chronic gastric electrical stimulation (GES) on the daily use of prokinetics and antiemetics, hospitalizations, total symptom score (TSS), SF-36 status for health-related quality of life (HQOL), and gastric emptying of a solid meal, we evaluated 37 gastroparetic patients preoperatively and 1 year after undergoing GES implant. Prokinetic and antiemetic use was significantly reduced. Of 27 patients on at least one prokinetic at baseline, 8 were off at 1 year. Twenty-six patients requiring antiemetics before surgery decreased to 17. Mean TSS was significantly reduced and the reduction for patients off medications was significantly better than for patients still on medications. Overall SF-36 scores for HQOL were significantly improved, and patients off antiemetics had a significantly higher HQOL score than for patients on antiemetics at 1 year. Hospitalizations decreased from 50 ± 10 days for the year prior to GES therapy to 14± 3 days (P < 0.05). However, gastric emptying was not significantly improved. Conclusions are as follows. (1) Chronic GES significantly reduced the use of prokinetic/antiemetic medications and the need for hospitalization in gastropraretic patients, whose clinical and quality of life outcomes also significantly improved (2) These data provide evidence of the positive economic impact of this new therapy on long-term clinical outcomes in gastroparetic patients not responding to standard medical therapy.
Similar content being viewed by others
References
Hornbuckle K, Barnett JL: The diagnosis and work up of the patients with gastroparesis. J Clin Gastroenterol 30:117–124, 2000
Soykan I, Sivri B, Sarosiek I, Kieman B, McCallum RW: Demography, clinical characteristic, psychological and abuse profiles, treatment, and long-term follow-up of patients with gastroparesis. Dig Dis Sci 43:2398–2404, 1998
Kendall BJ, McCallum RW: Gastroparesis and the current use of prokinetic drugs. Gastroenterologist 1:107–114, 1993
Koch KL: Diabetic gastropathy: gastric neuromuscular dysfunction in diabetes mellitus, a review of symptoms, pathophysiology, and treatment. Dig Dis Sci 44:1061–1075, 1994
Hasler WL: Gastric neurostimulation for gastroparesis: Time to pick up the pace. Gastroenterology 125:979–981, 2003
Bortolotti M: The “electrical way” to cure gastroparesis. Am J Gastroenterol 97:1874–1883, 2002
Lin ZY, Forster J, Sarosiek I, McCallum RW: Review article: Treatment of gastroparesis with electrical stimulation. Dig Dis Sci 48(5):837–848, 2003
Familoni BO, Abell TL, Nemoto D, Voeller G, Salem A, Gabor O: Electrical stimulation at a frequency higher than basal rate in human stomach. Dig Dis Sci 42:885–891, 1997
Forster J, Sarosiek I, Delcore R, Lin ZY, Raju GS, McCallum RW: Gastric pacing is a new surgical treatment for gastroparesis. Am J Surg 182:676–681, 2001
Abell T, McCallum RW, Hocking M, Koch K, Abrahamssion H, LeBlang I, Lindberg G, Konturek J, Nowak T, Quigley EMM, Tougas G, Starkebaum W: Gastric electrical stimulation for medically refractory gastroparesis. Gastroenterology 125:421–428, 2003
Abell TL, Cutsem EV, Abrahamsson H, Huizinga JD, Kontruek JW, Galmiche JP, Voeller G, Filez L, Everts B, Waterfall WE, Domschke W, des Varanbes SB, Familoni BO, Bourgeois IM, Janssens J, Tougas G: Gastric electrical stimulation in intractable symptomatic gastroparesis. Digestion 66:204–212, 2002
Lin ZY, Forster J, Sarosiek I and McCallum RW: Treatment of diabetic gastroparesis by highDfrequency gastric electrical stimulation. Diabetes Care 27:1071–1076, 2004
McElhinney C, Sarosiek I, Lin Z, McCallum RW: Comparison of hospitalizations, medications, and quality of life in patients receiving gastric electrical stimulation (GES) therapy for severe gastroparesis. Gastroenterology 122:A–82, 2002 (abstract)
Soykan I, Sarodiek I, McCallum RW: The effect of chronic oral domperidone therapy on GI symptoms, gastric emptying and quality of life in patients with gastroparesis. Am J Gastrointerol 92:976–980, 1997
Richards RD, Davenport K, McCallum RW: The treatment of idiopathic and diabetic gastroparesis with acute intravenous and chronic oral erythromycin. Am J Gastroenterol 88:203–207, 1993
Abell TL, Hocking M, McCallum R, Koch K, Nowak T, Diabaise JK: LongDterm hospitalization outcomes and economic impact of gastric electrical stimulation (GES) in patients with drug refractory gastroparesis. Gastroenterology 120(5):A–408, 2001 (abstract)
Forster J, Sarosiek I, Lin ZY, Durham S, Denton S, Roeser K, McCallum RW: Further experience with gastric stimulation to treat drug refractory gastroparesis. Am J Surg 186(6):690–695, 2003
Tougas G, Eaker EY, Abell TL, Abrahamsson H, Boivin M, Chen J, Hocking MP, Quigley EMM, Koch K, Tokayer AZ, Stanghellini V, Chen Y, Huizinga JD, Ryden J, Bourgeois I, McCallum RW: Assessment of gastric emptying using a low fat meal: Establishment of international control values. Am J Gastroenterol 95(6):1456–1462, 2000
Ware JE Jr: SF–36 Health Survey, manual and interpretation guide. Boston, MA, Health Institute, New England Medical Center, 1993
Ware JE, Kosinski M, Keller SD: SFD36 Physical and Mental Health Summary Scales: A userõs manual. Boston, MA, Health Assessment Lab, 1994
Koch KL, Stern RM, Stewart WR, Vasey MW: Gastric emptying and gastric myoelectrical activity in patients with diabetic gastroparesis: effect of longDterm domperidone treatment. Am J Gastroenterol 84:1069–1075, 1989
Cuts TF, Abell TL, Karas JG, Kuns J: Symptom improvement from prokinetic therapy corresponds to improved quality of life in patients with severe dyspepsia. Dig Dis Sci 41:1369–1378, 1996
Tack J, Coulie B, Van Cutsem E, Ryden J, Janssens KU: The influence of gastric electrical stimulation on proximal gastric motor and sensory function in severe idiopathic gastroparesis. Gastroenterology 116:G4733, 1999
Tougas G, Huizinga JD: Gastric pacing as a treatment for intractable gastroparesis: Shocking news? Gastroenterology 114:598–601, 1998
Author information
Authors and Affiliations
Corresponding author
Additional information
This study was supported in part by Medtronic, Inc. Part of this work was presented orally at the 2002 Annual AGA/DDW Meeting in San Francisco, California.
Rights and permissions
About this article
Cite this article
Lin, Z., McELHINNEY, C., Sarosiek, I. et al. Chronic Gastric Electrical Stimulation for Gastroparesis Reduces the Use of Prokinetic and/or Antiemetic Medications and the Need for Hospitalizations. Dig Dis Sci 50, 1328–1334 (2005). https://doi.org/10.1007/s10620-005-2782-7
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/s10620-005-2782-7